(+)-(R)-5,6,7,8-tetrahydro-6-(methylamino)carbazole-3-carboxamide succinate (1:1), monohydrate,
3-methylamino-6-carboxamido-1,2,3,4-tetrahydrocarbazole,
Allegro,
Frova,
frovatriptan,
frovatriptan succinate,
Frovelan,
SB 209509,
VML-251,
VML251,
158930-17-7,
Frovatriptan succinate hydrate,
Frovatriptan succinate [USAN],
Frovatriptan Succinate monohydrate,
UNII-D28J6W18HY,
D28J6W18HY,
NCGC00183880-01,
Frovatriptan succinate (USAN),
butanedioic acid,(6R)-6-methylamino-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide;hydrate,
(+)-(R)-2,3,4,9-Tetrahydro-3-(methylamino)-1H-carbazole-6-carboxamide butanedioate (1:1), monohydrate,
(+)-(R)-5,6,7,8-Tetrahydro-6-(methylamino)carbazole-3-carboxamide succinate (1:1), monohydrate,
1H-Carbazole-6-carboxamide, 2,3,4,9-tetrahydro-3-(methylamino)-, (R)-, butanedioate (1:1), monohydrate,
Butanedioic acid, compd. with (R)-2,3,4,9-tetrahydro-3-(methylamino)-1H-carbazole-6-carboxamide (1:1), monohydrate,
C14H17N3O.C4H6O4.H2O,
AC1L49EG,
DSSTox_CID_28982,
DSSTox_RID_83247,
DSSTox_GSID_49056,
SCHEMBL2321442,
CHEMBL2138684,
DTXSID2049056,
CTK4C9886,
Tox21_113606,
SB 209509-AX,
AKOS030241886,
API0000570,
LS-173538,
CAS-158930-17-7,
FT-0668872,
D04264,
Frovatriptan succinate monohydrate, >=97% (HPLC),
J-009548,
Frovatriptan succinate, United States Pharmacopeia (USP) Reference Standard,
(3R)-2,3,4,9-Tetrahydro-3-(methylamino)-1H-carbazole-6-carboxamide Butanedioic Acid Monohydrate,
Butanedioic acid, compd. with (R)-2,3,4,9-tetrahydro-3-(methylamino)-1H-carbazole-6-carboxamide, hydrate (1:1:1),
butanedioic acid; (6R)-6-(methylamino)-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide; hydrate,
Frova,
Frovatriptan succinate,
Frovatriptan,
Frovelan,
Miguard,
Migard,
Frova (TN),
VML-251,
SB-209509ax,
VML 251,
CID152943,
C14-H17-N3-O.C4-H6-O4.H2-O,